CFH and hemolytic-uremic syndrome: Interestingly, recent studies of CM-HUS associated with mutations in complement-related serum factors reveal that serum complement is not activated per se, but activation is caused as a result of defective interaction of complement regulatory proteins, such as factor H, with cell surfaces (39).